Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride

被引:10
作者
Cheng, Xiongkai [1 ]
Sun, Min [1 ]
Gao, Yan [1 ]
Cao, Fengliang [1 ]
Zhai, Guangxi [1 ]
机构
[1] Shandong Univ, Coll Pharm, Dept Pharmaceut, Jinan 250012, Peoples R China
关键词
Ambroxol Hydrochloride (Amb); osmotic pump controlled-release tablet; orthogonal design; in vitro release; pharmacokinetics; DRUG-DELIVERY-SYSTEM; ASYMMETRIC-MEMBRANE; HYDROPHILIC POLYMERS; SOLUBLE DRUG; TABLET;
D O I
10.3109/10837451003774385
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of the present study was to design and evaluate an osmotic pump-based drug delivery system for controlling the release of Ambroxol Hydrochloride (Amb). Citric acid, lactose and polyethylene glycol 6000 (PEG 6000) were employed as osmotic agents. Surelease EC containing polyethylene glycol 400 (PEG 400) controlling the membrane porosity was used as semi-permeable membrane. The formulation of tablet core was optimized by orthogonal design and evaluated by weighted mark method. The influences of the amount of PEG 400 and membrane thickness on Amb release were investigated. The optimal osmotic pump tablet (OPT) was evaluated in different release media and at different stirring rates. The major release power confirmed was osmotic pressure. The release of Amb from OPT was verified at a rate of approximately zero-order, and cumulative release percentage at 12 h was 92.6%. The relative bioavailability of Amb OPT in rabbits relative to the commercial sustained capsule was 109.6%. Our results showed that Amb OPT could be a practical preparation with a good prospect.
引用
收藏
页码:392 / 399
页数:8
相关论文
共 28 条
[1]  
*CHIN PHARM COMM, 2005, PHARM PEOPL REP CHIN, P75
[2]   Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets [J].
Garg, Amit ;
Gupta, Mukur ;
Bhargava, H. N. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 67 (03) :725-731
[3]   ASYMMETRIC-MEMBRANE TABLET COATINGS FOR OSMOTIC DRUG-DELIVERY [J].
HERBIG, SM ;
CARDINAL, JR ;
KORSMEYER, RW ;
SMITH, KL .
JOURNAL OF CONTROLLED RELEASE, 1995, 35 (2-3) :127-136
[4]   Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC [J].
Ishikawa, T ;
Watanabe, Y ;
Takayama, K ;
Endo, H ;
Matsumoto, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 202 (1-2) :173-178
[5]  
[金玲宇 JIN Lingyu], 2008, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V25, P593
[6]  
Kanagale P, 2007, AAPS PHARMSCITECH, V8
[7]   Oral sustained delivery of ambroxol from in situ-gelling pectin formulations [J].
Kubo, W ;
Miyazaki, S ;
Dairaku, M ;
Togashi, M ;
Mikami, R ;
Attwood, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 271 (1-2) :233-240
[8]   Bioequivalence assessment of ambroxol tablet after a single oral dose administration to healthy male volunteers [J].
Lee, HJ ;
Joung, SK ;
Kim, YG ;
Yoo, JY ;
Han, SB .
PHARMACOLOGICAL RESEARCH, 2004, 49 (01) :93-98
[9]   Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet [J].
Liu, Longxiao ;
Xu, Xiangning .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 352 (1-2) :225-230
[10]   Solubility-modulated monolithic osmotic pump tablet for atenolol delivery [J].
Liu, Longxiao ;
Wang, Xiaocui .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 68 (02) :298-302